Cardiovascular disease (CVD) is the leading cause of death worldwide, resulting in over 17 million deaths annually. According to the CDC, one-third of all U.S. deaths are caused by heart disease, stroke, or other cardiovascular diseases.
Meridian is conducting a phase 3 clinical research study for an investigational medication looking to reduce the risk of heart attack or stroke in those with cardiovascular disease.
Must be age 40 or older
Must be diagnosed with cardiovascular disease
Must be on a stable and high-intensity lipid-lowering regimen consisting of a statin medication, such as atorvastatin or rosuvastatin (participants using a different high-intensity statin must be able to switch to atorvastatin or rosuvastatin to be eligible)
May receive reimbursement for travel and expenses
Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can talk to a Meridian enrollment specialist about this study by calling (912) 623-2240 (New York) or (402) 934-7563 (Cincinnati).
Submit your information
Binghamton: Meridian Clinical Research, 1290 Upper Front Street, Binghamton, NY 13901
Endwell: Meridian Clinical Research, 415 Hooper Road, Endwell, NY 13760
After you submit your information, a Meridian enrollment specialist will contact you.
Participating in a study is an important decision and completely voluntary — we’re here to help you before, during, and after studies.
Please note: Health insurance is NOT required to join.
Will I benefit from this study?
You are not guaranteed to benefit from being in a clinical study. However, information gathered in this study may help uncover better ways to treat condition(s) for you and others worldwide.
Is participation voluntary after I submit my information?
Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the investigational medication being studied, your role in the trial, potential side effects, tests that will be performed, and the number of visits required. You will need to sign an informed consent form to join the study only after you fully understand your role in the study. If you decide to participate and change your mind, you can leave at any time for any reason.
Will I get a physical exam?
If you join the study, you will receive a physical exam. You may also receive specific exams or tests — the results of which will be shared with you.
Will I receive reimbursement?
After you submit your information, a Meridian enrollment specialist will call you to talk about the study. Reimbursement for study-related assessments and travel is available for eligible participants.
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.